IFNA2 蛋白
Quick Overview for IFNA2 蛋白 (ABIN6700936)
抗原
See all IFNA2 蛋白蛋白类型
宿主
资源
应用范围
纯度
-
-
Supplier Product No.
- 009-001-v19-0100
-
Supplier
- Rockland
-
原理
- Human Interferon-alpha 2b Recombinant Protein
-
纯化方法
- Interferon-alpha 2b purity was determined to be greater than 98% as determined by HpLC and by reducing and non-reducing SDS-pAGE.
-
内毒素水平
- Measured by LAL is typically ≤ 1 EU/μg protein.
-
Biological Activity Comment
- The activity is determined by the ability induce antiviral activity.
-
-
-
-
应用备注
-
Application Note: Interferon-alpha 2b Recombinant Protein has been tested by SDS-PAGE and is suitable as a control for polyclonal or monoclonal anti-Interferon-alpha 2b in immunological assays.
Other: User Optimized
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
-
Reconstitution_Buffer: Restore with deionized water (or equivalent)
Reconstitution_Volume: 100 μL
-
缓冲液
-
Buffer: None
Stabilizer: None
-
储存液
- Without preservative
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store vial at 4° C prior to restoration. Dilute only prior to immediate use. Maintain sterility. This product DOES NOT contain preservative. DO NOT VORTEX. We recommend adding a carrier protein such as HSA or BSA to 0.1% (i.e. 1.0 mg/mL). For best results aliquot contents and freeze at -20° C or colder. Avoid cycles of freezing and thawing. Centrifuge vial before each opening to dislodge contents from the cap and to clarify if contents are not clear after standing at room temperature.
-
有效期
- 6 months
-
-
- IFNA2 (Interferon, alpha 2 (IFNA2))
-
别名
- IFNA2
-
背景
-
Synonyms: Interferon alpha-A (LeIF A)Type I Interferon, Alpha 2
Background: Interferon-alpha 2b (IFNα 2b) is a Type I interferon made by leukocytes during viral infection. It has anti-viral and non-proliferative activity induced by JAK1-STAT signaling. IFN-alphas are the most widely used type for therapeutic purposes. IFNα 2b is a variant of IFNα 2a that differs by one amino acid. Recombinant human IFNα 2b is a non-glycosylated protein, containing 166 amino acids, with a molecular weight of 19.4 kDa.
-
UniProt
- P01563
-
途径
- JAK/STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
抗原
-